Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Copaxone Growth Helps Teva Offset Declining Generics Business

Aug 01 2005

• By Andrew Shelton

Related Content

Biogen Idec Refocusing On U.S. Avonex Sales While Awaiting Tysabri's Fate

Jul 27 2005

Teva's Biaxin XL Generic Would Irreparably Harm Abbott, Court Rules

Jun 06 2005

Copaxone Reaches MS Market Share High Following Tysabri Withdrawal

May 03 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window